Some observations on the inhibition of salivation by St 155 [2-(2,5-dichlorophenylamine)-2-imidazoline hydrochloride, Catapres®, Catapresan®]
- 31 January 1969
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 5 (2) , 168-172
- https://doi.org/10.1016/0014-2999(69)90025-9
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Mechanisms of the pressor and depressor actions of St 155 (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, catapres®)European Journal of Pharmacology, 1968
- Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 115)European Journal of Pharmacology, 1968
- Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155)European Journal of Pharmacology, 1968
- Evidence for a central hypotensive mechanism of 2-(2,6-dichlorophenylamino)-2-imidazoline (catapresan, ST-155)European Journal of Pharmacology, 1968
- Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HClEuropean Journal of Pharmacology, 1967
- Acute hypotensive action of 2-(2,6-dichlorophenylamino)- 2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral arteryEuropean Journal of Pharmacology, 1967
- THE PRESENCE OF BETA‐RECEPTORS IN THE SUBMAXILLARY GLAND OF THE DOGBritish Journal of Pharmacology and Chemotherapy, 1967
- Effect of a new hypotensive drug, ST155, on the systemic circulationAmerican Heart Journal, 1966
- Conditioned physiological adaptation to anticholinergic drugsAmerican Journal of Physiology-Legacy Content, 1966
- Classical and physiologic adaptive conditioned responses to anticholinergic drugs in conscious dogsInternational Journal of Neuropharmacology, 1966